Resultados: 3

    Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults

    This guideline covers general principles for prescribing and managing withdrawal from opioids, benzodiazepines, gabapentinoids, Z‑drugs and antidepressants in primary and secondary care. It does not cover gabapentinoids prescribed for epilepsy, nor opioids prescribed for acute or cancer pain, or at th...

    Alcohol interventions in secondary and further education

    This guideline covers interventions in secondary and further education to prevent and reduce alcohol use among children and young people aged 11 up to and including 18. It also covers people aged 11 to 25 with special educational needs or disabilities in full-time education. It will also be relevant to c...

    mhGAP Mental Health Gap Action Programme Scaling up care for mental, neurological, and substance use disorders

    mhGAP is WHO’s action plan to scale up services for mental, neurological and substance use disorders for countries especially with low and lower middle incomes. The priority conditions addressed by mhGAP are: depression, schizophrenia and other psychotic disorders, suicide, epilepsy, dementia, disorder...